Dana-Farber COO Dr. William Hahn recognized for contributions to cancer research

William Hahn, MD, PhD, is one of three recipients of the Hope Funds 2023 Award of Excellence. The award is given to individuals who have contributed to basic, clinical and medical research in cancer or prominent advocacy and philanthropy for cancer research.

Advertisement

Dr. Hahn currently serves as executive vice president and chief operating officer of Dana-Farber Cancer Institute in Boston, according to an April 10 news release. He is also the William Rosenberg Professor of Medicine at Boston-based Harvard Medical School.

Dr. Hahn conducts research as an institute member of the Broad Institute of the Massachusetts Institute of Technology and Harvard and was elected to the Association of American Physicians and the National Academy of Medicine.

The other recipients are Nathanael Gray, PhD, and Alexander Varshavsky, PhD.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Leadership

Advertisement

Comments are closed.